TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
INCR

InterCure Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

5.20$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

InterCure Ltd. (INCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 270 million ILS. Tick rows to compare them in a chart.

All figures in millions of ILS.

Tick rows to compare them in a chart (up to 4)

Income Statement INCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5.7 1.4 – 0.0 0.0 8.9 65 220 389 356 239 270
1.9 0.5 – 0.0 – 7.4 33 129 234 250 209 237
3.8 0.9 – 0.0 – 1.5 32 91 155 105 30 33
0.1 – – – – 1.7 1.6 1.2 0.6 0.4 0.4 0.4
3.2 2.0 1.4 1.1 9.8 79 20 45 92 64 63 60
6.4 3.4 1.4 1.1 9.8 4.9 70 63 104 147 97 26
-2.7 -2.5 1.2 -4.0 -11 -3.4 -38 28 51 -42 -67 6.7
0.1 0.2 0.4 0.6 1.0 2.0 0.5 5.0 15 24 21 20
-3.8 -1.9 0.3 -5.3 -13 -6.6 -38 19 44 -61 -87 -44
0.0 -0.8 3.1 0.7 -1.2 -0.7 -2.3 11 0.1 2.2 -15 -7.3
-3.8 -1.9 0.3 -5.3 -13 -5.9 -37 4.7 45 -62 -68 -36
-3.8 -1.6 -1.1 -1.1 -10 -3.8 -35 31 70 -24 -51 -7.3

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?